PCR Perspectives

By PCR

Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with expert insights and perspectives. These interviews explore the techniques, tools, and key... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about PCR Perspectives:

How many episodes does PCR Perspectives have?

The podcast currently has 42 episodes available.

PCR Perspectives episodes:

February 05, 2026 Should we consider TTVR in patients with straightforward anatomy who are eligible for T-TEER?
Lukas Stolz and Rebecca Hahn discuss advances in transcatheter tricuspid valve intervention, emphasising that reducing tricuspid regurgitation (TR) to mild levels is key for improving patient outcomes, including mortality and heart failure hospitalisations. Decision-making between transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) depends on anatomy, imaging, and patient factors like pacemakers or bleeding risk.
Hosted on Acast. See acast.com/privacy for more information.
...more
7min
January 29, 2026 Is iatrogenic atrial septum defect closure a necessary procedure?
Philipp Lurz and Saibal Kar discuss iatrogenic atrial septal defects from transseptal procedures. Small ones usually close on their own, while large defects causing significant shunting need closure to prevent right heart overload. Some moderate defects may be beneficial by decompressing the left atrium, so closure isn’t always needed. With the increasing amount of procedures, understanding the hemodynamics is also key to safe management.
Hosted on Acast. See acast.com/privacy for more information.
...more
7min
January 08, 2026 How to manage patients with aortic stenosis and coronary artery disease?
Tiffany Patterson and Davide Capodanno address the increasingly common scenario of managing coronary artery disease (CAD) in patients undergoing TAVI. With up to half of TAVI candidates presenting with CAD, they highlight new evidence from NOTION-3 showing that revascularization reduces major adverse cardiac events. The takeaway: CAD in TAVI patients matters, should be assessed thoughtfully, and evidence is evolving to guide both lesion selection and timing.
Hosted on Acast. See acast.com/privacy for more information.
...more
5min
December 18, 2025 How are the 2025 ESC/EACTS valvular guidelines going to impact my mitral programme?
Francesco Maisano interviews Michael Borger, co-chair of the 2025 ESC/EACS valvular heart disease guidelines, on their practical impact. The updated guidelines emphasize earlier intervention in primary mitral regurgitation, especially for asymptomatic patients with risk factors, while surgery remains preferred for low-risk patients.
Michael Borger stresses the importance of a multidisciplinary team approach, high-volume centres for complex cases, and timely, evidence-based interventions to improve patient outcomes.
Hosted on Acast. See acast.com/privacy for more information.
...more
7min
December 11, 2025 What are the key steps in pre procedural assessment for successful LAA closure?
Lorenz Räber and Kasper Korsholm highlight why pre-procedural imaging—particularly cardiac CT—has become essential for successful left atrial appendage occlusion (LAAO). They explain that the LAA is highly variable between patients, making detailed planning crucial for safety, device selection, and optimal procedural results.
Hosted on Acast. See acast.com/privacy for more information.
...more
8min
December 04, 2025 The D-PACE scoring system - Can we predict high-grade conduction disturbances after TAVI?
Michael Joner and Francesco Saia discuss the newly developed D-PACE Score, a tool designed to predict delayed AV block occurring more than 24 hours after TAVI—an unmet clinical need given that current risk models focus mainly on early events.
The next steps aim to refine the algorithm and integrate it into standardized pathways for conduction-disturbance management after TAVI.
Hosted on Acast. See acast.com/privacy for more information.
...more
6min
November 27, 2025 How do we meet the needs of women with heart valve disease?
In this #pcrlv2025 conversation, Ellen Ross and Marta Sitges discuss the recent initiative from Global Heart Hub, a patient association: an in-depth look at the situation of women living with heart valve disease, the gaps identified, and the call to action that followed.

They reflect on what these specific needs are, why they’re often overlooked, and how clinicians can adapt their approach to offer more meaningful support to women throughout their journey.

Hit play to hear their perspectives and understand what can truly move the needle in daily practice.
Hosted on Acast. See acast.com/privacy for more information.
...more
7min
November 21, 2025 What are the key learnings from the 7-year follow-up of PARTNER 3?
Listen to this PCR London Valves 2025 interview with Philippe Généreux and Philippe Pibarot, who explore the 7-year results of PARTNER 3 in low-risk patients.

They walk through the main findings of this TAVR versus SAVR comparison in symptomatic severe aortic stenosis (AS). At 7 years, the primary endpoint — the composite of mortality, stroke and rehospitalisation — shows similar rates between both strategies.

The conversation then turns to valve durability and whether the early promises of TAVR are being fulfilled when compared with surgery, what still needs to be improved on each side, and how these long-term data might influence clinical practice now that two strong options exist for low-risk patients.

They conclude by highlighting how Heart Team discussions will become even more crucial in this context.

Curious to learn more? Hit play!
Hosted on Acast. See acast.com/privacy for more information.
...more
9min
November 21, 2025 How are the new 2025 ESC/EACTS valvular guidelines going to impact my tricuspid programme?
While the PCR London Valves 2025 Course is underway, Francesco Maisano and Fabien Praz discuss how the latest ESC/EACTS valvular guidelines affect clinical practice.

What’s changing in surgery? How do repair and replacement strategies differ under the new recommendations, and what’s the impact on transcatheter interventions?

Discover key insights from this exclusive interview: watch the whole exchange now!
Hosted on Acast. See acast.com/privacy for more information.
...more
6min
November 13, 2025 How to manage the challenges of TAVI in bicuspid disease?
What makes TAVI in bicuspid aortic valve disease so challenging—and how can those challenges be overcome?
In this #europcr 2025 expert discussion, Chiara De Biase, Kentaro Hayashida, and Didier Tchetche share practical insights on navigating anatomical variability, refining patient selection, and optimising valve sizing.
They also address the critical role of calcification and how it can influence procedural outcomes. Whether you're performing TAVI in complex cases or building your expertise, this conversation offers valuable takeaways you won’t want to miss!
Hosted on Acast. See acast.com/privacy for more information.
...more
6min

FAQs about PCR Perspectives:

How many episodes does PCR Perspectives have?

The podcast currently has 42 episodes available.